Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Extension Safety and Efficacy Study of SAR442168 in Participants With Relapsing Multiple Sclerosis

NCT03996291 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT03996291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03996291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Extension Safety and Efficacy Study of SAR442168 in Participants With Relapsing Multiple Sclerosis
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Completed
Start date
September 23, 2019
Completion date
November 26, 2024
Enrollment
125 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing multiple sclerosis